Galapagos NV
25.30
22-November-24 10:18:00
15 minutes delayed
Stocks
+1.26
+5.24%
Today's range
24.04 - 25.37
ISIN
BE0003818359
Source
Cboe
-
18 May 2021 15:01:00 By Nasdaq GlobeNewswire
-
Galapagos refocuses pipeline and rightsizes operations
06 May 2021 15:01:00 By Nasdaq GlobeNewswire
-
Transparency notification received from The Capital Group
04 May 2021 15:01:00 By Nasdaq GlobeNewswire
-
Galapagos creates new subscription right plans
30 Apr 2021 15:01:00 By Nasdaq GlobeNewswire
-
22 Apr 2021 23:01:00 By Nasdaq GlobeNewswire
-
Extension of lock-up period in Gilead-Galapagos collaboration agreement
08 Apr 2021 15:01:00 By Nasdaq GlobeNewswire
-
Publication of the annual report and invitation to the ordinary shareholders’ meeting
25 Mar 2021 15:01:00 By Nasdaq GlobeNewswire
-
Galapagos appoints Bart Filius as President and Chief Operating Officer
24 Mar 2021 15:01:00 By Nasdaq GlobeNewswire
-
Galapagos increases share capital through subscription right exercises
19 Mar 2021 16:01:00 By Nasdaq GlobeNewswire
-
GALAPAGOS REPORTS PRIMARY ENDPOINT FOR THE ONGOING FILGOTINIB MANTA AND MANTA-RAy SAFETY STUDIES
04 Mar 2021 00:49:18 By Nasdaq GlobeNewswire
-
Transparency notification received from The Capital Group
03 Mar 2021 15:15:00 By Nasdaq GlobeNewswire
-
Pipeline and capital for growth
18 Feb 2021 15:01:00 By Nasdaq GlobeNewswire
-
Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF
10 Feb 2021 08:00:00 By Nasdaq GlobeNewswire
-
The Capital Group holds 10.03% of Galapagos shares
09 Feb 2021 15:01:01 By Nasdaq GlobeNewswire
-
NICE recommends Jyseleca® ▼(filgotinib) on NHS in landmark decision for rheumatoid arthritis
21 Jan 2021 01:08:24 By Nasdaq GlobeNewswire
-
Gilead holds 25.54% of Galapagos shares
11 Jan 2021 15:01:00 By Nasdaq GlobeNewswire
-
Galapagos to present at 39th Annual J.P. Morgan Healthcare Conference
06 Jan 2021 08:30:00 By Nasdaq GlobeNewswire
-
Selvita completes acquisition of Fidelta from Galapagos
04 Jan 2021 15:01:00 By Nasdaq GlobeNewswire